2m 2m 2m 2m 2m 2m 2m
P3 HEALTH PTR-A (PIII)
NASDAQ
$10.53-$2.26 (-17.71%)
Price as of Jun 03, 2026 7:23 PM EDT- $40.5MMarket Cap
- 88.37%1-Year Change
- Medical Care FacilitiesIndustry
P3 HEALTH PTR-A (PIII)
$10.53-$2.26 (-17.71%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B -3.68% | 1.5B +17.15% | 1.3B +20.67% | 1.0B +20,814.50% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.4B -3.68% | 1.5B +17.15% | 1.3B +20.67% | 1.0B +20,814.50% | |
Sales and Marketing Expense | 918,000 -31.03% | 1.3M -58.83% | 3.2M -36.56% | 5.1M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 84.2M -2.20% | 86.1M -0.71% | 86.7M -0.70% | 87.3M N/A | |
Total Operating Expenses | 1.7B -5.04% | 1.8B +26.97% | 1.4B -45.05% | 2.6B N/A | |
Operating Profit | -270.3M -15.70% | -320.7M +90.95% | -167.9M -89.24% | -1.6B +1,063.42% | |
Interest Income | 1.6M -4.38% | 1.7M N/A | N/A N/A | N/A N/A | |
Interest Expense | -55.0M +148.20% | -22.2M +38.71% | -16.0M +40.17% | -11.4M -8.79% | |
Interest Income and Expense and Net | -53.4M +160.78% | -20.5M +28.15% | -16.0M +40.17% | -11.4M -8.79% | |
Total Nonoperating Income and Expense | -50.8M -446.08% | 14.7M +192.82% | -15.8M -1,397.29% | 1.2M +121.57% | |
Income before Taxes | -321.1M +4.92% | -306.0M +66.54% | -183.7M -88.22% | -1.6B +1,062.51% | |
Income Taxes | 2.0M -53.84% | 4.4M +62.78% | 2.7M +44.74% | 1.9M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -147.9M +8.91% | -135.8M +135.14% | -57.8M -78.61% | -270.1M +329.98% | |
Net Income from Continuing Operations Applicable to Common | -321.1M +4.92% | -306.0M +66.54% | -183.7M -88.22% | -1.6B +2,382.68% | |
Basic EPS and Net Income | -45.26 +4,714.89% | -0.94 +54.10% | -0.61 -90.62% | -6.50 N/A | |
Diluted EPS and Net Income | -45.26 +4,090.74% | -1.08 +71.43% | -0.63 -90.31% | -6.50 N/A | |
Basic Weighted Average Shares | 3.3M -97.75% | 145.2M +52.99% | 94.9M +228,113.76% | 41,579 N/A | |
Diluted Weighted Average Shares | 3.3M -97.78% | 147.0M -50.10% | 294.6M +708,406.70% | 41,579 N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 25.0M -35.56% | 38.8M +6.87% | 36.3M +107.10% | 17.5M -87.52% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 25.0M -35.56% | 38.8M +6.87% | 36.3M +107.10% | 17.5M -87.52% | |
Total Current Assets | 133.1M -27.73% | 184.1M +10.92% | 166.0M +64.88% | 100.7M -49.62% | |
Accumulated Depreciation | 8.3M +21.14% | 6.8M +43.23% | 4.8M +82.41% | 2.6M +1,337.57% | |
Property and Plant and Equipment and Net | 3.4M -41.16% | 5.7M -33.99% | 8.7M -1.73% | 8.8M +9.83% | |
Total Long-Term Assets | 27.8M +44.62% | 19.2M -1.72% | 19.5M -97.48% | 775.9M -64.15% | |
Total Assets | 656.6M -16.18% | 783.4M -9.01% | 861.0M -1.78% | 876.6M -62.92% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 45.0M -30.71% | 65.0M 0.00% | 65.0M +1,693.10% | 3.6M +0.009% | |
Total Current Liabilities | 545.3M +9.84% | 496.4M +65.82% | 299.4M +23.88% | 241.7M +21.58% | |
Total Long-Term Debt | 228.4M +154.25% | 89.8M -17.07% | 108.3M +14.72% | 94.4M +18.03% | |
Total Long-Term Liabilities | 9.3M -64.20% | 26.0M -78.87% | 123.0M +9.60% | 112.2M +10.95% | |
Total Liabilities | 796.9M +25.71% | 633.9M +48.35% | 427.3M +20.74% | 353.9M +17.99% | |
Retained Earnings | -651.1M +29.40% | -503.2M +36.98% | -367.3M +18.67% | -309.5M +685.29% | |
Total Stockholders Equity | -155.2M -304.42% | 75.9M -46.57% | 142.1M +2,327.91% | 5.9M -93.55% | |
Total Shares Outstanding | 3.3M -97.98% | 162.9M -74.00% | 626.3M +157.56% | 243.2M +2.12% | |
Cash Flow | |||||
Cash from Operating Activities | -91.2M -17.15% | -110.1M +44.85% | -76.0M -39.67% | -126.0M N/A | |
Capital Expenditures | N/A N/A | 0 -100.00% | 1.8M -18.18% | 2.2M N/A | |
Cash from Investing Activities | 129,000 -99.11% | 14.5M +895.02% | -1.8M -76.37% | -7.7M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 72.8M -26.28% | 98.8M -1.56% | 100.3M +782.04% | 11.4M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -18.92% -12.48% | -21.61% +62.99% | -13.26% -91.08% | -148.73% N/A | |
Return on Assets | -20.55% +24.36% | -16.52% +148.46% | -6.65% -60.11% | -16.67% N/A | |
Return on Equity | 373.15% +399.49% | -124.59% +59.57% | -78.08% -86.05% | -559.55% N/A | |
Revenue Growth | -3.68% -121.46% | 17.15% -17.00% | 20.67% -99.90% | 20,814.50% N/A | |
Current Ratio | 0.24 -34.19% | 0.37 -33.12% | 0.55 +33.09% | 0.42 N/A | |
Cash Ratio | 0.05 -41.30% | 0.08 -35.53% | 0.12 +67.08% | 0.07 N/A | |
Debt-to-Equity Ratio | -1.76 -186.38% | 2.04 +67.21% | 1.22 -92.72% | 16.75 N/A | |
Debt-to-Assets Ratio | 0.42 +110.73% | 0.20 -1.84% | 0.20 +79.89% | 0.11 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow